CWR 1QCY19 long

Cures Within Reach improves patient quality and length of life by leveraging the speed, safety and cost-effectiveness of medical repurposing research, driving more treatments to more patients more quickly.

Cures is the philanthropic leader in drug, device and nutraceutical repurposing research, which has the potential to transform the lives of patients with unsolved diseases by delivering treatments that can be used in the near-term.

Our Functions

Value Driving Catalyst
• Bringing stakeholders together to undertake repurposing research opportunities

Value Driving Facilitator
• Building, managing and growing CureAccelerator as a central repurposing platform and creating other opportunities to bring together repurposing research stakeholders
• Fostering collaboration and conversation to create market impact and health savings, including new economic incentives for the repurposing of generic drugs

Our Success Stories and Case Studies

Our facilitated research has created more than 13 treatments in use by patients today or funded for larger confirmatory clinical trials.

Type 1 Diabetes

Repurposing a Generic Tuberculosis Vaccine to Treat Type 1 Diabetes


Repurposing a Transplant Drug Saves Kids with ALPS, a Rare but Deadly Blood Disorder

Prostate Cancer

Repurposing a Liver Cyst Laser Device to Eliminate Side Effects of Prostate Cancer Treatment


Repurposing a Device to Help Restore Function Lost to Brain and Nerve Disorders



CA logo stackIn 2015, we launched CureAccelerator, the world’s first interactive, online platform dedicated to repurposing research. By connecting researchers, funders, the biomedical industry and patient groups, CureAccelerator drives the pace of repurposing research, to drive more treatments to more patients more quickly.


Our History

George and Judy GoldmanIn 1998, Goldman Philanthropic Partners (GPP), a private operating foundation, was founded to accelerate the discovery of new treatments to improve the quality of life for people with catastrophic diseases. Dr. Bruce Bloom, currently the Chief Collaboration Officer of Healx, became Executive Director of Goldman Philanthropic Partnerships (GPP) in 2002.  In 2005, Partnership for Cures was established as a 501(c)(3) public charity to carry on the GPP mission, and in 2009, we narrowed our focus to repurposing research, with Bruce as President & Chief Science Officer of our newly-focused nonprofit.  

In 2012, we formally changed our name to Cures Within Reach to better reflect the focus of its mission: repurposing drugs, devices, nutraceuticals, and other treatments to drive more treatments to more patients more quickly. In 2017, Bruce became CEO of Cures Within Reach, and Barbara Goodman joined the leadership team. In 2019, Bruce left to pursue other opportunities.  


Click here to sign up for our eNewsletter today!

Please include your Full Name* and Email Address*


If the link above doesn't work, please contact our Admin support at with your Full Name and Email Address to sign up!


Cures Within Reach

134 N. LaSalle, #1130
Chicago, IL 60602

All funds donated to Cures Within Reach may be tax deductible for federal income tax purposes. 

Partnership for Cures DBA Cures Within Reach is recognized by the IRS as a 501(c)3 tax-exempt not-for-profit organization, tax ID 20-3620169.


Sunday the 20th. Copyright 2018 Cures Within Reach.